Skip to main content

Eli Lilly’s $123 Billion Market Value Drop: A Strategic Buying Opportunity?

JPMorgan analyst says Eli Lilly will remain a leader in weight loss drugs.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.